GoodRx EV/EBIT GDRX

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2022.

Today, Oct 23, 2026: 18.7×
5-year median: 27.9×
Against its 5-year history: 33rd; percentile: 0 is its lowest day, 100 its highest
5-year range: 9.9× to 500×
Peer median: 13.1×

GoodRx's EV/EBIT is 18.7× as of Oct 23, 2026.

That is below its 5-year median of 27.9×, lower than on 67% of days in the last 5 years.

Over that time it ranged from 9.9× in Feb 2026 to 500× in Apr 2023.

The median for 10 application software stocks of a similar size is 13.1×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	18.7×	9.9×	19.5×
2025	13.8×	13.7×	67.7×
2024	62.2×	56.1×	66.0×
2023	130×	123×	500×
2022	122×	46.7×	491×

Against its peers

Companies in Software - Application nearest GoodRx's size, closest first, today.

Company	EV/EBIT
GDRXGoodRx	18.7×
LZLegalzoom.Com	32.1×
UPWKUpwork	6.9×
HSTMHealthstream	37.8×
EVEREverQuote	7.4×
TASKTaskUs	7.6×
EVTCEVERTEC	16.6×
YEXTYext	15.7×
MNTNMNTN	10.5×
INODInnodata	32.6×
NRDSNerdwallet	7.3×
Peer median	13.1×

Where GoodRx ranks

#29of 62Application software stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on GoodRx

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.